Synthesis, biophysical properties, and stability studies of mixed backbone oligonucleotides containing segments of methylphosphotriester internucleotidic linkages

Tetrahedron

Volumn 52, Issue 46, 1996, Pages 14419-14436

  Iyer, Radhakrishnan P ^a   Yu, Dong ^a   Jiang, Zhiwei ^a   Agrawal, Sudhir ^a  

^a HYBRIDON INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OLIGONUCLEOTIDE;

ARTICLE; DRUG STABILITY; DRUG SYNTHESIS; MASS SPECTROMETRY; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

EID: 0030580399     PISSN: 00404020     EISSN: None     Source Type: Journal    
DOI: 10.1016/0040-4020(96)00875-7     Document Type: Article

References (30)

1. 1. Miller, P. S.; Fang, K. N.; Kondo, N. S.; Ts'o, P. O. P. J. Am. Chem. Soc. 1971, 93, 6657-65.
2. 2. (a) Liu, A. -L.; Jack, W. E.; Modrich, P. J. Biol. Chem. 1981, 256, 13200;
3. (b) Weinfeld, M.; Livingston, D. C. Biochemistry 1986, 25, 5083.
4. 3. For selected reviews see: (a) Uhlmann, E.; Peyman, A. Chem. Rev. 1990, 90, 544-84;
5. (b) Agrawal, S.; Iyer, R. P. Curr. Op. Biotech. 1995, 6, 12-19 and references therein;
6. (c) Thuong, N. T.; Helene, C. Angew. Chem. Intl. Ed. Engl. 1993, 32, 666-690.
7. 4. Zhang, R.; Iyer, R. P.; Tan, W.; Yu, D.; Zhang, X.; Lu, Z.; Zhao, H.; Agrawal, S. J. Pharmacol. Exp. Therap. 1996, 278, 971-79.
8. 5. (a) Furdon, P.; Dominski, Z.; Kole, R. Nucl. Acids Res. 1989, 17, 9193;
9. (b) Agrawal, S.; Mayrand, S. H.; Zamecnik, P. C.; Pederson, T. Proc. Natl. Acad. Sci. (USA) 1990, 87, 1401-4.
10. 6. (a) Koole, L. H.; van Genderen, M. H. P.; Buck, H. M. J. Am. Chem. Soc. 1987, 109, 3916-21;
11. (b) van Genderen, M. H. P.; Koole, L. H.; Aagaard, O. M.; van Lare, C. E. J.; Buck, H. M. Biopolymers, 1987, 20, 1447-61.
12. 7. Miller, P. S.; Dreon, N.; Pulford, S. M.; McParland, K. M. J. Biol. Chem. 1980, 255, 9659-9665.
13. 8. (a) Iyer, R. P.; Yu, D.; Ho, N.-H.; Devlin, T.; Agrawal, S. J. Org. Chem. 1995, 60, 8132-33;
14. (b) Yu, D.; Iyer, R. P.; Ho, N.-H.; Devlin, T.; Agrawal, S. (submitted);
15. PNT was accomplished using this protocol. (equation presented)
16. 9. (a) Vinogradov, S.; Asseline, U.; Thuong, N. T. Tetrahedron Lett. 1993, 34, 5899-5902;
17. (b) Hayakawa, Y.; Hirose, M.; Hayakawa, M.; Noyori, R. J. Org. Chem. 1995, 60, 925-30;
18. (c) Alul, R. H.; Singman, C. N.; Zhang, G.; Letsinger, R. L. Nucl. Acids Res. 1991, 19, 1527-32;
19. (d) Kuijpers, W. H. A.; Huskens, J.; Koole, L. H.; van Boeckel, C. A. A. Nucl. Acids Res. 1990, 18, 5197-5205;
20. (e) Koole, L. H.; Moody, M. H.; Broeders, N. L. H. L.; Quaedflieg, P. L. J. M.; Kuijpers, W. H. A.; van Genderen, M. H. P.; Coenen, A. J. J. M.; van der Wal, S.; Buck, H. M. J. Org. Chem. 1989, 54, 1657-64.
21. 10. (a) Beaucage, S. L.; Caruthers, M. H. Tetrahedron Lett. 1981, 22, 1859-62;
22. For reviews see: (i) Beaucage, S. L.; Iyer, R. P. Tetrahedron 1992, 48, 2223-2311;
23. (ii) Beaucage, S. L. in Protocols for Oligonucleotides and Analogs; Agrawal, S., Ed.; Humana Press: Totowa, NJ, 1993; Vol. 20, pp. 33-61.
24. 11. Iyer, R. P.; Egan, W.; Regan, J. B.; Beaucage, S. L. J. Am. Chem. Soc. 1990, 112, 1253-54.
25. 12. For selected examples see: (a) De Mesmaeker, A.; Lebreton, J.; Waldner, A.; Fritsch, V.; Wolf, R. M. Bioorg. Med. Chem. Lett. 1994, 4, 873-78;
26. (b) Caulfield, T. J.; Prasad, C. V. C.; Prouty, C. P.; Saha, A. K.; Sardaro, M. P.; Schairer, W. C.; Yawman, A.; Upson, D. A.; Kruse, L. I. Bioorg. Med. Chem. Lett. 1993, 3, 2771-76;
27. (c) Kutterer, K. M. K.; Just, G. Bioorg. Med. Chem. Lett. 1994, 4, 435-38;
28. (d) Bevierre, M.-O.; De Mesmaeker, A.; Wolf, R. M.; Freier, S. Bioorg. Med. Chem. Lett. 1994, 4, 237-240. For additional examples see Ref. 3b.
29. 13. Agrawal, S.; Iyer, R. P. Drugs of the Future 1995, 20, 344-351.
30. 14. For details, see: Iyer, R. P.; Yu, D.; Agrawal, S. Bioorg. Chem. 1995, 23, 1-21.